Publication | Open Access
NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018
76
Citations
46
References
2018
Year
Lymphoid NeoplasiaT-cell LymphomasImmunodeficienciesMedicineImmunologyClinical TrialsPathologyNccn Guidelines InsightsImmune Checkpoint InhibitorAutoimmunityNatural KillerAdult T-cell Leukemia-lymphomaImmunotherapyOncologyLung CancerCancer ResearchNccn Guidelines
Natural killer (NK)/T-cell lymphomas are a rare and distinct subtype of non-Hodgkin's lymphomas. NK/T-cell lymphomas are predominantly extranodal and most of these are nasal type, often localized to the upper aerodigestive tract. Because extranodal NK/T-cell lymphomas (ENKL) are rare malignancies, randomized trials comparing different regimens have not been conducted to date and standard therapy has not yet been established for these patients. These NCCN Guidelines Insights discuss the recommendations for the diagnosis and management of patients with ENKL as outlined in the NCCN Guidelines for T-Cell Lymphomas.
| Year | Citations | |
|---|---|---|
Page 1
Page 1